The Deal
Saturday, November 21, 
7:00 pm

Could Bayer be taken over by Pfizer?

  Share     E-Mail    Discussion    Print Story
pfizer.jpgTakeover rumors of Bayer AG by New York-based Pfizer Inc. boosted shares of the German drugs and chemicals group Tuesday morning.

Continue reading below

Also on Dealscape

A Reuters report said a Pfizer purchase of Bayer could be complicated since the company would have to break up Bayer's chemical-drugs combo. Nonetheless, Pfizer is a highly acquisitive company with a penchant for transformative megadeals like its acquisitions of Pharmacia and Warner-Lambert. However, it hasn't made any major purchases in a few years, and its blockbuster cholesterol fighter Lipitor goes off patent in 2011 -- perhaps these developments are feeding the speculation it will bid on Bayer. - Maria Woehr

See story from Reuters
See related story about Pfizer's most recent purchase from TheDeal.com



Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Avaya Inc.'s Mohamad Ali on the company's next target.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Managing your shareholder base

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.


Editor's Note

Editor's letter: Nov. 16, 2009

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.